BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8374878)

  • 81. Multifocal renal cell tumors: a retrospective analysis of 56 patients treated with radical nephrectomy.
    Steinbach F; Stöckle M; Griesinger A; Störkel S; Stein R; Miller DP; Hohenfellner R
    J Urol; 1994 Nov; 152(5 Pt 1):1393-6. PubMed ID: 7933167
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Flow cytometric analysis of the DNA profile of renal cell carcinoma.
    Ekfors TO; Lipasti J; Nurmi MJ; Eerola E
    Pathol Res Pract; 1987 Feb; 182(1):58-62. PubMed ID: 3588404
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Well differentiated clear cell renal carcinoma: significance of nuclear deoxyribonucleic acid patterns studied by flow cytometry.
    Rainwater LM; Hosaka Y; Farrow GM; Lieber MM
    J Urol; 1987 Jan; 137(1):15-20. PubMed ID: 3795358
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Localized renal cell carcinoma.
    Russo P
    Curr Treat Options Oncol; 2001 Oct; 2(5):447-55. PubMed ID: 12057108
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Tumor-cell proliferation and prognosis in renal-cell carcinoma.
    Larsson P; Roos G; Stenling R; Ljungberg B
    Int J Cancer; 1993 Oct; 55(4):566-70. PubMed ID: 8406982
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Intratumoral heterogeneity of DNA content in renal cell carcinoma and its prognostic significance.
    Ruiz-Cerdá JL; Hernández M; Sempere A; O'Connor JE; Kimler BF; Jiménez-Cruz F
    Cancer; 1999 Aug; 86(4):664-71. PubMed ID: 10440695
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications.
    Larsson P; Roos G; Stenling R; Ljungberg B
    Scand J Urol Nephrol; 1996 Dec; 30(6):445-50. PubMed ID: 9008023
    [TBL] [Abstract][Full Text] [Related]  

  • 88. DNA value and prognosis of renal tumors. Differences between childhood and adult tumors.
    Yoshida S
    Acta Pathol Jpn; 1992 Mar; 42(3):185-92. PubMed ID: 1315114
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Flow cytometric DNA analysis of interleukin-2 responsive renal cell carcinoma.
    Gomella LG; Ehya H; Steinberg SM; Rupp M; Merino M; Robertson C; Linehan WM
    J Surg Oncol; 1993 Aug; 53(4):252-5. PubMed ID: 8341057
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Clinicopathological studies and flow cytometric analysis on renal cell carcinoma after incidental finding].
    Shishido S; Tachibana M; Muraki J; Ohigashi T; Hayashi S; Shibayama T; Deguchi N; Baba S; Jitsukawa S; Hata M
    Nihon Hinyokika Gakkai Zasshi; 1991 Jan; 82(1):87-93. PubMed ID: 2046203
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The role of nuclear morphometry for predicting disease outcome in patients with localized renal cell carcinoma.
    Nativ O; Sabo E; Raviv G; Medalia O; Moskovitz B; Goldwasser B
    Cancer; 1995 Oct; 76(8):1440-4. PubMed ID: 8620421
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Renal tumors in young adults.
    Boykin WH; Bright KE; Zeidman EJ; Thompson IM
    Urology; 1992 Dec; 40(6):503-5. PubMed ID: 1466101
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [A clinical study of 104 patients with tongue cancer and the relationship between DNA ploidy and prognosis in 41 cases].
    Tomiyama Y; Yoshida J; Honjo Y; Otozai S; Mitani K
    Nihon Jibiinkoka Gakkai Kaiho; 2003 Nov; 106(11):1084-92. PubMed ID: 14672033
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Studies on DNA ploidy of biopsy and surgical specimen for renal cell carcinoma].
    Hongo F
    Nihon Hinyokika Gakkai Zasshi; 1997 Aug; 88(8):712-8. PubMed ID: 9293747
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Deoxyribonucleic acid content in metastatic renal cell carcinoma: clinical implications.
    Ljungberg B; Roos G; Stenling R
    Semin Surg Oncol; 1988; 4(3):165-8. PubMed ID: 3187294
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Metastatic renal cell carcinoma treated with purified leukocyte interferon. Clinical response in relation to tumor DNA content.
    Bengtsson NO; Lenner P; Sjödin M; Hietala SO; Stenling R; Lundgren E; Ljungberg B
    Acta Oncol; 1991; 30(6):713-7. PubMed ID: 1958391
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Prognostic factors in renal cell carcinoma.
    Lanigan D
    Br J Urol; 1995 May; 75(5):565-71. PubMed ID: 7613789
    [No Abstract]   [Full Text] [Related]  

  • 98. Renal cell carcinoma.
    Godley PA; Ataga KI
    Curr Opin Oncol; 2000 May; 12(3):260-4. PubMed ID: 10841199
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Clinicopathologic study of 97 cases of small renal cell carcinomas using DNA flow cytometric analyses.
    Shishikura Y; Suzuki M
    Pathol Int; 1996 Dec; 46(12):947-52. PubMed ID: 9110346
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Tumour DNA content and skeletal metastases in renal cell carcinoma. A preliminary report.
    Ljungberg B; Roos G; Toolanen G
    J Bone Joint Surg Br; 1990 Jan; 72(1):111-5. PubMed ID: 2298767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.